TiGenix appoints Gri-Cel CEO and COO to Board of Directors TiGenix appoints Gri-Cel CEO and COO to Board of Directors Following strategic investment of EUR12m by Grifols Sitka Biopharma appoints Sean Cunliffe as Chief Executive Sitka Biopharma appoints Sean Cunliffe as Chief Executive Canadian biotechnology firm is developing a treatment for bladder cancer Richard Sachse takes Chief Scientific Officer role at Aeterna Zentaris Richard Sachse takes Chief Scientific Officer role at Aeterna Zentaris Takes responsibility for all global research and development activities at the Canadian firm John van der Valk appointed MD of UBM Live Amsterdam John van der Valk appointed MD of UBM Live Amsterdam Takes responsibility for overseeing the company’s CPhI brand Kemal Malik joins Bayer Board of Management and takes responsibility for Innovation Kemal Malik joins Bayer Board of Management and takes responsibility for Innovation Professor Wolfgang Plischke will retire on 30 April Nuevolution appoints Ton Berkien as Chief Business Officer Nuevolution appoints Ton Berkien as Chief Business Officer He will lead the commercial and business development efforts of the Copenhagen-based firm Celerion appoints John Horkulak as Executive Director, Eurasian Site Operations Celerion appoints John Horkulak as Executive Director, Eurasian Site Operations Will help expand early phase patient capabilities in Europe and Asia Lorus Therapeutics completes new executive management team Lorus Therapeutics completes new executive management team Avanish Vellanki and Gregory Chow join Canadian biopharmaceutical company as Chief Business Officer and Chief Financial Officer Aptuit names Jonathan Goldman as Chief Executive Aptuit names Jonathan Goldman as Chief Executive He joins the firm from global contract research organisation ICON Clinical Research Hiroharu Okochi named new President of Harlan Japan Hiroharu Okochi named new President of Harlan Japan Harlan says there is growth potential in Asia-Pacific region Glenmark appoints Philip Andrew Gioia as President North America and Global API Business Glenmark appoints Philip Andrew Gioia as President North America and Global API Business He joins the Indian pharmaceutical firm from Bausch & Lomb Novasep promotes Nadege Laborde to President of Industrial Biotech Business Unit Novasep promotes Nadege Laborde to President of Industrial Biotech Business Unit Laborde has been with Novasep since 2000 Theravectys makes two appointments to strengthen executive committee Theravectys makes two appointments to strengthen executive committee Hires a Head of Clinical Development and a Head of Strategy and Business Development Harlan Korea names new President Harlan Korea names new President Kwan Goo Edmond (Ed) Cho takes responsibility for Harlan Contract Research Services\' business in Korea Owen Mumford makes a promotion Owen Mumford makes a promotion Modestino Graziano becomes Group Operations Director and joins the Board of Directors Valeant Pharmaceuticals makes new management appointment Valeant Pharmaceuticals makes new management appointment Former McKinsey partner joins the firm in January 2014 Lab M appoints Director of Sales & Marketing Lab M appoints Director of Sales & Marketing Wendy Martindale has broad commercial experience in the scientific and laboratory markets Novo Nordisk and Oxford University join forces to further enhance diabetes research Novo Nordisk and Oxford University join forces to further enhance diabetes research Twelve young researchers will be offered a three-year grant to support their research Dr Gerald Moeller becomes Vice-President of supervisory board at Genticel Dr Gerald Moeller becomes Vice-President of supervisory board at Genticel He is a former CEO of the Boehringer Mannheim Group Eclipse Magnetics appoints separation specialist Eclipse Magnetics appoints separation specialist Martyn Cotterill joins metal detection system manufacturer Camargo Pharmaceutical Services names Jim Beach as Chief Operating Officer Camargo Pharmaceutical Services names Jim Beach as Chief Operating Officer He joins the US drug development firm from Cardinal Health Celerion appoints Clayton Dehn as Executive Director, Metabolic Diseases Celerion appoints Clayton Dehn as Executive Director, Metabolic Diseases He joins the company with 15 years of experience in drug development Affimed Therapeutics appoints Chief Medical Officer Affimed Therapeutics appoints Chief Medical Officer Jens-Peter Marschner joins the firm from Merck KGaA ISPE names Thomas Zimmer as Vice President of European Operations ISPE names Thomas Zimmer as Vice President of European Operations He will be the primary European liaison to the ISPE HQ in Tampa, Florida